🟢 ADMA Biologics is trading 4.23% up today as major indexes rise

ADMA Biologics is trading +4.23% at $9.49 amid a broad September 21, 2026 risk-on rally.

• The S&P 500, Nasdaq, and Dow Jones are all higher, supporting biotechnology sentiment.
• No clear September 21 company-specific announcement was identified; recent coverage centers on prior earnings and guidance.
• Falling oil prices and easing Treasury-yield concerns are improving risk appetite.